Retatrutide (10mg)
Retatrutide (Triple Agonist)
Triple GLP-1/GIP/glucagon receptor agonist investigated in incretin receptor binding and metabolic pathway studies. For laboratory research only.
Purity
≥99% (HPLC verified)
Quality
CoA Included
Form
Lyophilised Powder
Shipping
Free over $400
Select Quantity — Buy More, Save More:
Product Specifications
Legal Disclaimer
This product is sold strictly for in-vitro laboratory research purposes only. It is not a therapeutic good, is not approved by the TGA, and is not intended for human or animal consumption, injection, or any diagnostic or therapeutic use.
For Research Purposes Only
This product is intended for laboratory research use only. Not for human consumption or clinical use. All research should be conducted in accordance with institutional guidelines and regulations. Peak Peptides Australia provides products exclusively for legitimate scientific research.
Related Research Peptides
Retatrutide (20mg)
Higher concentration triple GLP-1/GIP/glucagon receptor agonist for advanced incretin pathway research. For laboratory research purposes only.
$240.00 AUD
Tirzepatide (10mg)
Dual GIP/GLP-1 receptor agonist investigated in incretin receptor binding and glucose-dependent insulinotropic studies. For laboratory research only.
$75.00 AUD